US 11,986,524 B1
Methods for treatment of menopausal symptoms
Ralph L Peterson, Oakland, CA (US); and Renee D Williman, Oakland, CA (US)
Assigned to Next2Me, LLC, Oakland, CA (US)
Filed by Next2Me, LLC, Oakland, CA (US)
Filed on Jan. 22, 2024, as Appl. No. 18/418,822.
Application 18/418,822 is a continuation in part of application No. 18/400,485, filed on Dec. 29, 2023.
Application 18/400,485 is a continuation of application No. 18/111,702, filed on Feb. 20, 2023, granted, now 11,857,626, issued on Jan. 2, 2024.
Application 18/111,702 is a continuation in part of application No. 17/961,836, filed on Oct. 7, 2022, granted, now 11,612,630, issued on Mar. 28, 2023.
Application 17/961,836 is a continuation in part of application No. 17/732,639, filed on Apr. 29, 2022, granted, now 11,529,383, issued on Dec. 20, 2022.
Application 17/732,639 is a continuation in part of application No. 16/116,539, filed on Aug. 29, 2018, abandoned.
Application 16/116,539 is a continuation in part of application No. 14/223,392, filed on Mar. 24, 2014, abandoned.
Claims priority of provisional application 61/936,116, filed on Feb. 5, 2014.
Int. Cl. A61K 41/00 (2020.01); A61K 31/197 (2006.01); A61K 31/4188 (2006.01); A61K 31/4415 (2006.01); A61K 31/455 (2006.01); A61K 31/51 (2006.01); A61K 31/519 (2006.01); A61K 31/525 (2006.01); A61K 31/661 (2006.01); A61K 31/714 (2006.01); A61K 36/06 (2006.01); A61K 36/23 (2006.01); A61K 36/68 (2006.01); A61K 36/9068 (2006.01)
CPC A61K 41/0004 (2013.01) [A61K 31/197 (2013.01); A61K 31/4188 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/519 (2013.01); A61K 31/525 (2013.01); A61K 31/661 (2013.01); A61K 31/714 (2013.01); A61K 36/06 (2013.01); A61K 36/23 (2013.01); A61K 36/68 (2013.01); A61K 36/9068 (2013.01)] 5 Claims
 
1. A method of treating menopausal symptoms of a subject, comprising the steps of:
(i) providing a liquid composition comprising glycerin-based water, black cohosh in the range of from about 200.0 mg to about 750.0 mg, valerian root in the range of from about 200.0 mg to about 750.0 mg, sage in the range of from about 200.0 mg to about 750.0 mg, chasteberry in the range of from about 200.0 mg to about 750.0 mg, red clover in the range of from about 200.0 mg to about 750.0 mg, primrose in the range of from about 200.0 mg to about 750.0 mg, fenugreek in the range of from about 200.0 mg to about 750.0 mg, dong quai in the range of from about 200.0 mg to about 750.0 mg, licorice root in the range of from about 200.0 mg to about 750.0 mg, and cannabidiol in the range of from about 12.0 mg to about 15.0 mg;
(ii) subjecting said liquid composition to harmonic oscillation at a frequency in the range of 0.0001 kHz to 40000.0 kHz for a period of time in the range of 3.0 minutes to 60.0 minutes; and
(iii) delivering a therapeutically effective amount of said liquid composition to said subject.